Fig. 6

Immunotherapeutic and chemotherapeutic responses in high- and low-risk patients with HNSC. A Immunotherapeutic responses to anti-PD-1 therapy in high- and low-risk patients. B The P value is shown using Fisher’s exact test to detect whether the immunotherapeutic response rates of the high-risk and low-risk groups were significantly different. C Drugs in clinics or in test for HNSC with significant differential chemotherapeutic responses (P < 0.001) in high- and low-risk patients predicted by the pRRopheic package in the R language